Clinical trial
Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell…
NCT00003101 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003101 |
|---|---|
| Title | Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma |
| Official title | A Phase II Trial of Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, busulfan, lomustine, procarbazine hydrochloride, thiotepa, vincristine sulfate, autologous bone marrow transplantation, peripheral blood stem cell transplantation |
| Enrollment | 60 |
| Start date | Aug 1, 1997 |
| Primary completion | Jan 1, 2002 |
| Completion | Jan 1, 2002 |
| First posted | May 21, 2004 |
| Last update posted | Jun 25, 2013 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: